Table 1 Demographic and clinical characteristics of the study subjects
Parameter | PRP [i] group (number = 20) | PRP [ii] group (number = 20) | CS group (number = 20) | P |
|---|---|---|---|---|
Age (year) | 48.8 ± 7.45 | 48.8 ± 6.62 | 49.15 ± 6.06 | 0.975 |
Gender | ||||
Male | 3 (32%) | 2 (28%) | 2 (28%) | 0.676 |
Female | 17 (68%) | 18 (72%) | 18 (72%) | |
BMI | 29.07 ± 1.4 | 28.8 ± 2.22 | 28.47 ± 1.81 | 0.578 |
History of diabetes | 3 (15%) | 4 (20%) | 4 (20%) | 0.895 |
History of hypertension | 6 (30%) | 4 (20%) | 6 (30%) | 0.711 |
Duration of disease (month) | 24.1 ± 7.05 | 24.34 ± 5.88 | 23.3 ± 7.26 | 0.908 |
Lesion site | ||||
Right | 13 (65%) | 14 (70%) | 14 (70%) | 0.926 |
Left | 7 (35%) | 6 (30%) | 6 (30%) | |
Grade | ||||
Very mild | 3 (15%) | 3 (15%) | 2 (10%) | 0.390 |
Mild | 4 (20%) | 2 (10%) | 4 (20%) | |
Moderate | 13 (65%) | 15 (75%) | 14 (70%) | |
VAS | 7.65 ± 1.35 | 6.37 ± 2.01 | 6.7 ± 2 | 0.113 |
BCTQs | 25.45 ± 7.1 | 25.8 ± 6.16 | 25.55 ± 7.65 | 0.979 |
BCTQf | 17.05 ± 6.14 | 16.68 ± 6.12 | 16.5 ± 4.77 | 0.904 |
DML (ms) | 5 ± 1.12 | 4.79 ± 1.4 | 5.05 ± 1.19 | 0.794 |
SPL (ms) | 4.99 ± 1.04 | 4.6 ± 0.61 | 4.58 ± 0.49 | 0.156 |
Platelet whole blood (103/μL) | 194.3 ± 45.12 | 204.1 ± 48.34 | - | 0.051 |
Platelet PRP (103 /μL) | 412.1 ± 9.07 | 666.3 ± 101.4 | - | <0.0001* |